Microbiological success by fAUC/MIC against urogenital Neisseria gonorrhoeae at baseline in a phase II study evaluating single oral doses of gepotidacin
| fAUC/MIC (range) | n/N | Microbiological success (%) |
| ≥198 | 27/27 | 100 |
| 95 to 103 | 25/25 | 100 |
| 48 to 49 | 9/9 | 100 |
| 24 to 25 | 4/6 | 67 |
| 12 | 1/2 | 50 |
| Total | 66/69 | 96 |
Table reproduced with permission from Scangarella-Oman et al,21 under the Creative Commons Attribution License. Full terms at: https://creativecommons.org/licenses/by/4.0/.
fAUC/MIC, ratio of the area under the free-drug concentration–time curve to the MIC; MIC, minimum inhibitory concentration; n/N, number of subjects with culture-confirmed eradication of N. gonorrhoeae out of total microbiologically evaluable subjects.